User profiles for Thomas Wiesmann
Thomas WiesmannPhilipps Universität Marburg & Diakonie Klinikum Schwäbisch Hall Verified email at diakoneo.de Cited by 1728 |
[HTML][HTML] Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
…, M Weiss, D Zickler, T Wiesmann… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-…
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-…
[HTML][HTML] Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome (s)
Ehlers-Danlos syndrome (EDS, ORPHA98249) comprises a group of clinically and
genetically heterogeneous heritable connective tissue disorders, chiefly characterized by joint …
genetically heterogeneous heritable connective tissue disorders, chiefly characterized by joint …
Postoperative nausea and vomiting–a narrative review of pathophysiology, pharmacotherapy and clinical management strategies
T Wiesmann, P Kranke, L Eberhart - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Postoperative nausea and vomiting (PONV) are common complications concerning
patients undergoing general anesthesia. Intensive research was performed during the …
patients undergoing general anesthesia. Intensive research was performed during the …
[HTML][HTML] Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort
…, F Fichtner, C Nau, F Prätsch, T Wiesmann… - Critical Care, 2021 - Springer
Background Intensive Care Resources are heavily utilized during the COVID-19 pandemic.
However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon …
However, risk stratification and prediction of SARS-CoV-2 patient clinical outcomes upon …
[HTML][HTML] One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
…, B Grüner, D Zickler, T Wiesmann… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Results of many randomized trials on COVID-19 convalescent plasma (CCP)
have been reported, but information on long-term outcome after CCP treatment is limited. …
have been reported, but information on long-term outcome after CCP treatment is limited. …
[HTML][HTML] Tranexamic acid prophylaxis in hip and knee joint replacement
…, C Feldmann, H Wulf, T Wiesmann - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background The antifibrinolytic agent tranexamic acid (TXA) is widely used for the prevention
and treatment of hyperfibrinolytic states, such as in severe polytrauma. It can also be used …
and treatment of hyperfibrinolytic states, such as in severe polytrauma. It can also be used …
Continuous adductor canal block versus continuous femoral nerve block after total knee arthroplasty for mobilisation capability and pain treatment: a randomised and …
T Wiesmann, K Piechowiak, S Duderstadt… - Archives of orthopaedic …, 2016 - Springer
Introduction Continuous femoral nerve blocks for total knee arthroplasty can cause motor
weakness of the quadriceps muscle and thus prevent early mobilisation. Perioperative falls …
weakness of the quadriceps muscle and thus prevent early mobilisation. Perioperative falls …
The analgesic efficacy of liposomal bupivacaine compared with bupivacaine hydrochloride for the prevention of postoperative pain: a systematic review and meta …
HC Dinges, T Wiesmann, B Otremba, H Wulf… - Regional Anesthesia & …, 2021 - rapm.bmj.com
Background/Importance Liposomal bupivacaine (LB) is a prolonged release formulation of
conventional bupivacaine designed for prolonging local or peripheral regional single …
conventional bupivacaine designed for prolonging local or peripheral regional single …
[HTML][HTML] The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
…, C Keller, C Schade-Brittinger, C Rolfes, T Wiesmann - Leukemia, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 (coronavirus
disease 2019), which is associated with high morbidity and mortality, especially in …
disease 2019), which is associated with high morbidity and mortality, especially in …
Risks and benefits of ultrasound, nerve stimulation, and their combination for guiding peripheral nerve blocks: a retrospective registry analysis
…, J Schöpe, P Kessler, H Wulf, T Wiesmann… - Anesthesia & …, 2018 - journals.lww.com
BACKGROUND: Ultrasound, nerve stimulation, and their combination are all considered
acceptable ways to guide peripheral nerve blocks. Which approach is most effective and …
acceptable ways to guide peripheral nerve blocks. Which approach is most effective and …